Leonardo R. Cajero-Zul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Leonardo R. Cajero-Zul has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Martínez-Richa
Departamento de Química, División de Ciencias Naturales y Exactas, Universidad de Guanajuato, Noria Alta S/N, Guanajuato, Guanajuato 36050, México
2 shared publications - Edgar Benjamín Figueroa Ochoa
Universidad de Guadalajara
2 shared publications - Karla J. González-Iñiguez
Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Guadalajara 44430, Mexico
2 shared publications - Sergio Manuel Nuño Donlucas
Departamento de Ingenieria Quimica, Centro Universitario de Ciencias Exactas e Ingenierias, Universidad de Guadalajara, Guadalajara 44430, Mexico
2 shared publications
Latest Publications
- Open Access
Synthesis of Poly(L–lactide)–poly(ε–caprolactone)–poly(ethylene glycol) Terpolymer Grafted onto Partially Oxidized Carbon Nanotube Nanocomposites for Drug Delivery
Nanocomposites prepared with a terpolymer of poly(L–lactide) (PLLA)–poly(ε–caprolactone) (PCL)–poly(ethylene glycol) (PEG) and partially oxidized carbon nanotubes (CNTspo) were synthesized and characterized to evaluate their ability to act as an effective nanocarrier of the anticancer drug methotrexate. The homopolymers of PLLA and PCL were synthesized through ring-opening polymerization (ROP) and characterized through gel permeation chromatography (GPC). The PLLA–PCL–PEG terpolymers were synthesized through a four-step chemical route using oxalyl chloride as a linker agent and analyzed with 1H–NMR, 13C–NMR, and FTIR spectroscopies. Additionally, the nanocomposites were characterized through FTIR, and X-ray photoelectron spectroscopy (XPS), as well as the differential scanning calorimetry (DSC) technique. XPS analysis revealed that PLLA–PCL–PEG terpolymer chains are grafted onto CNTspo. Moreover, evaluations through FTIR and DSC strongly suggest that the PCL-rich domains are preferentially oriented toward CNTspo. The release tests exhibited a “burst effect” profile, which was more evident in the terpolymers than in the nanocomposites. Five models were used to assess methotrexate’s in vitro release. For the nanocomposites, the best fit to the experimental data was obtained using the first-order model, whereas the results obtained from the Korsmeyer–Peppas model indicated that Fickian diffusion drives methotrexate’s release.
Open AccessSynthesis of Poly(L–lactide)–poly(ε–caprolactone)–poly(ethylene glycol) Terpolymer Grafted onto Partially Oxidized Carbon Nanotube Nanocomposites for Drug Delivery
Nanocomposites prepared with a terpolymer of poly(L–lactide) (PLLA)–poly(ε–caprolactone) (PCL)–poly(ethylene glycol) (PEG) and partially oxidized carbon nanotubes (CNTspo) were synthesized and characterized to evaluate their ability to act as an effective nanocarrier of the anticancer drug methotrexate. The homopolymers of PLLA and PCL were synthesized through ring-opening polymerization (ROP) and characterized through gel permeation chromatography (GPC). The PLLA–PCL–PEG terpolymers were synthesized through a four-step chemical route using oxalyl chloride as a linker agent and analyzed with 1H–NMR, 13C–NMR, and FTIR spectroscopies. Additionally, the nanocomposites were characterized through FTIR, and X-ray photoelectron spectroscopy (XPS), as well as the differential scanning calorimetry (DSC) technique. XPS analysis revealed that PLLA–PCL–PEG terpolymer chains are grafted onto CNTspo. Moreover, evaluations through FTIR and DSC strongly suggest that the PCL-rich domains are preferentially oriented toward CNTspo. The release tests exhibited a “burst effect” profile, which was more evident in the terpolymers than in the nanocomposites. Five models were used to assess methotrexate’s in vitro release. For the nanocomposites, the best fit to the experimental data was obtained using the first-order model, whereas the results obtained from the Korsmeyer–Peppas model indicated that Fickian diffusion drives methotrexate’s release.
- Open Access
- 19 August 2024
- Published by MDPI AG in Preprints.org
Synthesis of poly(L-Lactide)–Poly(-Caprolactone)–Poly(ethylene Glycol) Terpolymer Grafted onto Partially Oxidized Carbon Nanotube Nanocomposites for Drug Delivery
Nanocomposites prepared with a terpolymer of poly(L-lactide) (PLLA)–poly(-caprolactone) (PCL)–poly(ethylene glycol) (PEG) and partially oxidized carbon nanotubes (CNTspo) were synthesized and characterized to evaluate their ability to act as an effective nanocarrier of the anticancer drug methotrexate. The homopolymers of PLLA and PCL were synthesized through ring-opening polymerization (ROP) and characterized through gel permeation chromatography (GPC). The PLLA–PCL–PEG terpolymers were synthesized through a four-step chemical route using oxalyl chloride as a linker agent and analyzed through 1H-NMR, 13C-NMR, and FT-IR spectroscopies. Also, the nanocomposites were characterized through FT-IR, 1H-NMR, and X-ray photoelectron spectroscopy (XPS) spectroscopies and, using the differential scanning calorimetry (DSC) technique. XPS analysis revealed that CNTspo is grafted to PLLA–PCL–PEG terpolymer. Besides, evaluation through FT-IR and DSC strongly suggests that the CNTspo are preferentially oriented to the PCL-rich domains. The release tests exhibited a “burst effect” profile, which was more evident in the terpolymers than in the nanocomposites. Five models were used to assess the methotrexate in vitro release. For the nanocomposites, the best fit to the experimental data was obtained using the first-order model, whereas the results obtained from the Korsmeyer–Peppas model indicated that a Fickian diffusion drives the methotrexate release.
- 19 August 2024
- Published by MDPI AG in Preprints.org
Open AccessSynthesis of poly(L-Lactide)–Poly(-Caprolactone)–Poly(ethylene Glycol) Terpolymer Grafted onto Partially Oxidized Carbon Nanotube Nanocomposites for Drug Delivery
Nanocomposites prepared with a terpolymer of poly(L-lactide) (PLLA)–poly(-caprolactone) (PCL)–poly(ethylene glycol) (PEG) and partially oxidized carbon nanotubes (CNTspo) were synthesized and characterized to evaluate their ability to act as an effective nanocarrier of the anticancer drug methotrexate. The homopolymers of PLLA and PCL were synthesized through ring-opening polymerization (ROP) and characterized through gel permeation chromatography (GPC). The PLLA–PCL–PEG terpolymers were synthesized through a four-step chemical route using oxalyl chloride as a linker agent and analyzed through 1H-NMR, 13C-NMR, and FT-IR spectroscopies. Also, the nanocomposites were characterized through FT-IR, 1H-NMR, and X-ray photoelectron spectroscopy (XPS) spectroscopies and, using the differential scanning calorimetry (DSC) technique. XPS analysis revealed that CNTspo is grafted to PLLA–PCL–PEG terpolymer. Besides, evaluation through FT-IR and DSC strongly suggests that the CNTspo are preferentially oriented to the PCL-rich domains. The release tests exhibited a “burst effect” profile, which was more evident in the terpolymers than in the nanocomposites. Five models were used to assess the methotrexate in vitro release. For the nanocomposites, the best fit to the experimental data was obtained using the first-order model, whereas the results obtained from the Korsmeyer–Peppas model indicated that a Fickian diffusion drives the methotrexate release.